文献速递肿瘤 PET/CT

前列腺癌患者68Ga-PSMA PET/CT显示胰腺炎远期表现

Late-Term Findings of Pancreatitis on 68 Ga-PSMA PET/CT in a Patient With Prostate Cancer.
PubMed 文献 · Clin Nucl Med · 2022-08-26

本文报道一例前列腺癌再分期行68Ga-PSMA PET/CT时,胰腺组织因既往胰腺炎出现弥漫性中度PSMA受体活化的病例,提示PSMA在良恶性疾病及多种生理组织中均可表达,报告时需注意陷阱与伪影。

要点

  • 68Ga-PSMA PET/CT用于前列腺癌生化复发、治疗反应和分期的评估。
  • PSMA受体活化可见于良恶性疾病及多种生理组织。
  • 既往胰腺炎可致胰腺弥漫性中度PSMA受体活化,属报告陷阱。

核心结论

  • 既往胰腺炎可导致胰腺组织在68Ga-PSMA PET/CT上出现弥漫性中度PSMA受体活化,报告时需注意此类陷阱与伪影。

研究设计与样本

  • 本文为病例报告,描述一例前列腺癌患者再分期行68Ga-PSMA PET/CT的影像表现。

主要发现

  • 该例前列腺癌再分期68Ga-PSMA PET/CT显示胰腺组织因既往胰腺炎出现弥漫性中度PSMA受体活化。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The 68 Ga-PSMA PET/CT imaging modality is used to evaluate biochemical recurrence, response to treatment, and staging in prostate cancer. Prostate-specific membrane antigen (PSMA) receptor activation can be seen in benign and malignant diseases as well as in many physiological tissues. Many pitfalls and artifacts have been reported when reporting 68 Ga-PSMA PET/CT. In this case, diffuse moderate PSMA receptor activation in pancreatic tissue due to the previous pancreatitis is presented in 68 Ga-PSMA PET/CT imaging modality that was performed for restaging of prostate cancer.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Tosunoğlu Z, Erol Fenercioğlu Ö, Beyhan E, et al. Late-Term Findings of Pancreatitis on 68 Ga-PSMA PET/CT in a Patient With Prostate Cancer. Clin Nucl Med. 2022. PMID: 36026591. doi:10.1097/RLU.0000000000004371

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。